Table of Contents

"1. Preventing Melanoma, Barbara Summerer, MD, Sewon Kang, MD, and Timothy Wang, MD, 2. Evolution of the Melanoma Staging System, Rohit R. Sharma, Glen C. Balch, and Charles M. Balch, 3. Less Common Variants of Cutaneous Melanoma, Raymond L. Barnhill and Kapil Gupta, 4. Controversies in the Management of the Regional Node Basin in Cutaneous Melanoma, Ioannis Hatzaras and Julie R. Lange, 5. Adjuvant Therapy for Melanoma, Tara C. Gangadhar and Lynn M. Schuchter, 6. RAF Kinase Inhibitor Therapy in Melanoma, James J. Harding and Paul B. Chapman, 7. Emerging Targets for Melanoma Therapy Besides BRAF, Young Kwang Chae, Sapna P. Patel, and Kevin B. Kim, 8. Ipilimumab: The New Frontier of T-Cell Antibodies: A Paradigm Shift in Immuno-Oncology, Steven J. O'Day, 9. Adoptive Cell Transfer Immunotherapy for Patients with Metastatic Melanoma, Crystal J. Hessman, Ashley A. Stewart, Akemi D. Miller, James C. Yang, and Steven A. Rosenberg, 10. Immunotherapies for Metastatic Melanoma, Kevin Conlon, 11. Updated Approach to the Patient with Metastatic Melanoma, Rodabe N. Amaria and Rene Gonzalez; ; "

About the Author

William H. Sharfman, MD, Associate Professor of Oncology, Associate Professor of Dermatology, Johns Hopkins School of Medicine

Jame Abraham, MD, FACP, is Bonnie Wells Wilson Distinguised Professor and Eminent Scholar, Chief Section of Hematology - Oncology, and Medical Director, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia